Towards a Better Understanding of GABAergic Remodeling in Alzheimer’s Disease

Epigenetic Regulations of GABAergic Neurotransmission: Relevance for Neurological Disorders and Epigenetic Therapy

Shrestha, S., & Offer, S. M. (2016) · Medical Epigenetics · doi:10.1159/000444713 · Cited by 8,951

2016 Alzheimer's disease facts and figures

Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051

2013 Alzheimer's disease facts and figures

Thies, W. H., & Bleiler, L. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.02.003 · Cited by 3,372

Candidate gene for the chromosome 1 familial Alzheimer’s disease locus

Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C.-E., Jondro, P. D., Schmidt, S. D., Wang, K., et al. (1995) · Science · doi:10.1126/science.7638622 · Cited by 2,577

Excitatory actions of gaba during development: the nature of the nurture

Ben-Ari, Y. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn920 · Cited by 2,448

Cortical inhibitory neurons and schizophrenia

Lewis, D. A., Hashimoto, T., & Volk, D. W. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1648 · Cited by 2,297

Tau-mediated neurodegeneration in Alzheimer’s disease and related disorders

Ballatore, C., Lee, V. M.-Y., & Trojanowski, J. Q. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2194 · Cited by 2,174

New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory?

Deng, W., Aimone, J. B., & Gage, F. H. (2010) · Nature reviews. Neuroscience · doi:10.1038/nrn2822 · Cited by 2,120

Exploring the Genetic Association of the ABAT Gene with Alzheimer’s Disease

Zheng, Q., Bi, R., Xu, M., Zhang, D., Tan, L., Lu, Y.-P., & Yao, Y. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02271-z · Cited by 14

Early spatial recognition memory deficits in 5XFAD female mice are associated with disruption of prefrontal parvalbumin neurons

Ganesh, A., Choudhury, W., & Coutellier, L. D. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149122 · Cited by 13

The Effect of γ-Aminobutyric Acid Addition on In Vitro Ruminal Fermentation Characteristics and Methane Production of Diets Differing in Forage-to-Concentrate Ratio

Wang, Y.-L., Zhang, Z.-H., Wang, W., Wu, Q., Zhang, F., Li, W., Li, S., Wang, W., Cao, Z., & Yang, H. (2023) · Fermentation · doi:10.3390/fermentation9020105 · Cited by 13

The Pathogenesis in Alzheimer's Disease: TREM2 as a Potential Target

Liu, G., Zhang, L., Fan, Y., & Ji, W. (2023) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2206150 · Cited by 13

Transcriptional changes in the rat brain induced by repetitive transcranial magnetic stimulation

Weiler, M., Stieger, K. C., Shroff, K., Klein, J. P., Wood, W. H., Zhang, Y., Chandrasekaran, P., Lehrmann, E., Camandola, S., Long, J. M., et al. (2023) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2023.1215291 · Cited by 15

c-Jun N-Terminal Kinases in Alzheimer’s Disease: A Possible Target for the Modulation of the Earliest Alterations

Busquets, O., Parcerisas, A., Verdaguer, E., Ettcheto, M., Camins, A., Beas‐Zárate, C., Castro-Torres, R. D., & Auladell, C. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-201053 · Cited by 14

Receptores neurais e a doença de Alzheimer: uma revisão sistemática da literatura sobre as famílias de receptores mais associadas a doença, suas funções e áreas de expressão

Câmara, A. B. (2019) · Jornal Brasileiro de Psiquiatria · doi:10.1590/0047-2085000000242 · Cited by 12

Tau phosphorylation and OPA1 proteolysis are unrelated events: Implications for Alzheimer's Disease

Alavi, M. V. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.119116 · Cited by 12

Reprogramming Human Adult Fibroblasts into GABAergic Interneurons

Bruzelius, A., Kidnapillai, S., Drouin‐Ouellet, J., Stoker, T. B., Barker, R. A., & Ottosson, D. R. (2021) · Cells · doi:10.3390/cells10123450 · Cited by 14

Structural and functional remodeling of neural networks in β-amyloid driven hippocampal hyperactivity

Li, J., Liu, Y., Yin, C., Zeng, Y., & Mei, Y. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102468 · Cited by 13

β-amyloid’s neurotoxic mechanisms as defined by in vitro microelectrode arrays: a review

O'connell, A., Quinlan, L. R., & Kwakowsky, A. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107436 · Cited by 12

SSADH Variants Increase Susceptibility of U87 Cells to Mitochondrial Pro-Oxidant Insult

Menduti, G., Vitaliti, A., Capo, C. R., Lettieri‐Barbato, D., Aquilano, K., Malaspina, P., & Rossi, L. C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124374 · Cited by 11

Emergency Department Visits for Psychotropic-Related Adverse Drug Events in Older Adults With Alzheimer Disease, 2013-2014

Sepassi, A., & Watanabe, J. H. (2019) · Annals of Pharmacotherapy · doi:10.1177/1060028019866927 · Cited by 11

Short chain fatty acids as epigenetic and metabolic regulators of neurocognitive health and disease

Mihaylova, M. M., & Stratton, M. S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816843-1.00023-0 · Cited by 11

Systems biology of Alzheimer’s Disease: a scoping review of key pathways and mechanisms

Bice, P. J., Nho, K. T., Ertekin‐Taner, N., & Saykin, A. J. (2026) · Molecular Neurodegeneration · doi:10.1186/s13024-026-00934-4 · Cited by 14

Metabolomic Investigation of Brain and Liver in Rats Fed Docosahexaenoic Acid in Regio‐ and Enantiopure Triacylglycerols

Pariyani, R., Zhang, Y., Haraldsson, G. G., Chen, K., Linderborg, K. M., & Yang, B. (2024) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202300341 · Cited by 10

Greater cognitive reserve is related to lower cortical excitability in healthy cognitive aging, but not in early clinical Alzheimer’s disease

Buss, S. S., Fried, P. J., Macone, J., Zeng, V., Zingg, E., Santarnecchi, E., Pascual‐Leone, Á., & Bartrés‐Faz, D. (2023) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2023.1193407 · Cited by 10

The neurogenic niche in Alzheimer’s disease

Wander, C. M., & Song, J. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.136109 · Cited by 9

Polymorphic Genetic Markers of the GABA Catabolism Pathway in Alzheimer’s Disease

Ciminelli, B. M., Menduti, G., Benussi, L., Ghidoni, R., Binetti, G. G., Squitti, R., Rongioletti, M. C. A., Nica, S., Novelletto, A., Rossi, L. C., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200429 · Cited by 9

Generalized correlation coefficient for genome-wide association analysis of cognitive ability in twins

Mohammadnejad, A., Nygaard, M., Li, S., Zhang, D., Xu, C., Li, W., Lund, J., Christiansen, L., Baumbach, J., Christensen, K., et al. (2020) · Aging · doi:10.18632/aging.104198 · Cited by 9

Inactivation of Presenilin in inhibitory neurons results in decreased GABAergic responses and enhanced synaptic plasticity

Lee, S. H., Bolshakov, V. Y., & Shen, J. (2021) · Molecular Brain · doi:10.1186/s13041-021-00796-5 · Cited by 8

Progesterone attenuates Aβ25–35-induced neuronal toxicity by activating the Ras signalling pathway through progesterone receptor membrane component 1

Wu, Z., Wu, H., Sun, S., Wu, H., Shi, W., Song, J., Liu, J., Zhang, Y., Bian, F., Jia, P., et al. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117360 · Cited by 9

Increased GABAergic development in iPSC-derived neurons from patients with sporadic Alzheimer’s disease

Tang, Y., Han, Y., Yu, H., Zhang, B., & Li, G. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135208 · Cited by 9

Voltage-Gated Na+ Channels in Alzheimer’s Disease: Physiological Roles and Therapeutic Potential

Baumgartner, T. J., Haghighijoo, Z., Goode, N. A., Dvorak, N. M., Arman, P., & Laezza, F. (2023) · Life · doi:10.3390/life13081655 · Cited by 10

Calorie Restriction Attenuates Memory Impairment and Reduces Neuroinflammation in Obese Aged Rats

Jantsch, J., Rodrigues, F. D. S., Dias, V. S., Fraga, G. D. F., Eller, S. C. W. D. S., Giovenardi, M., & Guedes, R. P. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04360-9 · Cited by 8

Review on pathogenesis and treatment of Alzheimer's disease

Cai, J., Liu, Y., & Fan, H. (2024) · Developmental Dynamics · doi:10.1002/dvdy.762 · Cited by 10

Triptolide injection reduces Alzheimer's disease‐like pathology in mice

Mao, R., Xu, S., Sun, G., Yu, Y., Zuo, Z., Wang, Y., Yang, K. Y., Zhang, Z., & Yang, W. (2023) · Synapse · doi:10.1002/syn.22261 · Cited by 8

Fluoroethylnormemantine (FENM) shows synergistic protection in combination with a sigma-1 receptor agonist in a mouse model of Alzheimer's disease

Freyssin, A., Carles, A., Guehairia, S., Rubinstenn, G., & Maurice, T. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109733 · Cited by 8

Neuroprotective potential of Betulinic acid against TIO2NP induced neurotoxicity in zebrafish

Kaur, K., Narang, R., & Singh, S. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112604 · Cited by 9

Editorial: Neuronal network dysfunction in neurodegenerative disorders

Kwakowsky, A., Prasad, A. A., Peña‐Ortega, F., & Lim, S. A. O. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1151156 · Cited by 8

Astrocyte dysfunction alters GABAergic communication and ammonia metabolism in the streptozotocin-induced sporadic Alzheimer's disease model

Brezolin, É. C., Gayger-Dias, V., Silva, V.-F. D., Cigerce, A., Schultz, B., Sobottka, T. M., Nardin, P., de Assis, A. M., Leite, M. C., Quincozes‐Santos, A., et al. (2024) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823241289036 · Cited by 7

Molecular signatures of regional vulnerability to tauopathy in excitatory cortical neurons

Broekaart, D. W. M., Sharma, A., Ramakrishnan, A., Chongtham, A., Günther, D. M., Subramaniyan, S., Wang, M., Patel, V., Zhang, B., Grinberg, L. T., et al. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02879-2 · Cited by 7

Beyond epilepsy: The expanding role of valproic acid in Alzheimer disease therapy – a review

Markowicz-Piasecka, M., Miłkowska, Z., Adla, S. K., Huttunen, K. M., & Pietrzak, B. (2025) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2025.103658 · Cited by 9

Neurotransmitter Systems in Alzheimer’s Disease

Ramı́rez-Expósito, M. J., Cueto‐Ureña, C., & Martı́nez-Martos, J. M. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48030334 · Cited by 7

Acupuncture Therapy on Dementia: Explained with an Integrated Analysis on Therapeutic Targets and Associated Mechanisms

Li, D., Yang, H., Lyu, M., Wang, J., Xu, W., & Wang, Y. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221018 · Cited by 7

Association between behavioural risks and Alzheimer's disease: Elucidated with an integrated analysis of gene expression patterns and molecular mechanisms

Li, D., Yang, H., Lyu, M., Zhou, L., Zhang, Y., Kang, C., Wang, J., & Wang, Y. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105207 · Cited by 7

Sex-dependent sensitivity to positive allosteric modulation of GABA action in an APP knock-in mouse model of Alzheimer's disease: Potential epigenetic regulation

Auta, J., Locci, A., Guidotti, A., Davis, J. M., & Dong, H. (2021) · Current Research in Neurobiology · doi:10.1016/j.crneur.2021.100025 · Cited by 8

Astrocyte response in Alzheimer’s disease: Good or bad?

Ismail, A., Al-Kuraishy, H. M., Al-Gareeb, A. I., Albuhadily, A. K., Yassen, A. S. A., Alexiou, A. T., Papadakis, M., & Batiha, G. E. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149971 · Cited by 6

Neurotransmitters and Immunity: Molecular Mechanisms, Biological Functions, Diseases, and Potential Therapeutic Targets

Li, G., Li, F., Tang, Y., Guo, S., Yao, Y., Yuan, F., Zhang, B., Jiang, Y. Y., Wang, J., Wu, D., et al. (2025) · MedComm · doi:10.1002/mco2.70556 · Cited by 6

Cross-Frequency Coupling as a Neural Substrate for Prediction Error Evaluation: A Laminar Neural Mass Modeling Approach

Ruffini, G., Lopez-Sola, E., Palma, R., Sanchez-Todo, R., Vohryzek, J., Castaldo, F., & Friston, K. J. (2026) · Neural Computation · doi:10.1162/neco.a.1537 · Cited by 8

Functional neuroanatomy and disorders of cognition

Nakhate, K. T., Borkar, C. D., & Bharne, A. P. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819445-4.00002-3 · Cited by 6

Effects of Medicinal Plants and Phytochemicals on Schizophrenia

Raju, N. R., Rashmitha, S., -, S. P., Torres, E. A., Kishor, M. R., & Achar, R. R. (2023) · Wiley eBooks · doi:10.1002/9781119794127.ch4 · Cited by 6

Modulation of pain sensitivity by Ascl1- and Lhx6-dependent GABAergic neuronal function in streptozotocin diabetic mice

Hwang, S.-M., Rahman, M. M., Go, E. J., Roh, J., Park, R. N. D. Y., Lee, S.-G., Nahm, M., Berta, T., Kim, Y. H., & Park, C. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.12.039 · Cited by 5

The medial septum-hippocampus-lateral septum circuitry in spatial memory: linking healthy function to early Alzheimer’s disease and translational opportunities

Song, Y., Ni, J., Qing, H., & Quan, Z. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00511-7 · Cited by 5

GABAA receptor agonist cinazepam and its active metabolite 3-hydroxyphenazepam act differently at the presynaptic site

Borisova, Т., Pozdnyakova, N., Dudarenko, M., Krisanova, N. V., & Andronati, S. A. (2021) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2021.03.013 · Cited by 5

The Effects and Safety of Gamma Rhythm Stimulation on Cognitive Function in Alzheimer’s Disease: A Systematic Review and Meta-Analysis

Wu, L., Wei, Y., He, K., & Gao, Q. (2025) · Neurorehabilitation and neural repair · doi:10.1177/15459683251360733 · Cited by 5

Evaluating the Diagnostic Value of Electrovestibulography (EVestG) in Alzheimer’s Patients with Mixed Pathology: A Pilot Study

Dastgheib, Z. A., Lithgow, B., & Moussavi, Z. (2023) · Medicina · doi:10.3390/medicina59122091 · Cited by 4

Zinc Oxide Nanoparticles Attenuated Neurochemical and Histopathological Alterations Associated with Aluminium Chloride Intoxication in Rats

Attia, F. M., Kassab, R. B., Ahmed-Farid, O. A.-H., Moneim, A. E. A., & El-Yamany, N. A. (2024) · Biological Trace Element Research · doi:10.1007/s12011-024-04292-4 · Cited by 4

Targeted Metabolomic Analysis of the Eye Tissue of Triple Transgenic Alzheimer’s Disease Mice at an Early Pathological Stage

Shen, L., Tang, X., Zhang, H., Zhuang, H., Jing, L., Zhao, Y., & Liu, X. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03533-2 · Cited by 4

Combination of MS Binding Assays and affinity selection mass spectrometry for screening of structurally homogenous libraries as exemplified for a focused oxime library addressing the neuronal GABA transporter 1

Gabriel, J., Höfner, G., & Wanner, K. T. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112598 · Cited by 3

Altered GABAergic signaling and chloride homeostasis in eye movement circuits during late neurodevelopment: implications for Alzheimer’s disease therapy

Porcher, C., Rivera, C., Medina, I., & Koric, L. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1675799 · Cited by 5

Changes in the cortical GABAergic inhibitory system in a Spinal Muscular Atrophy mouse model

Menduti, G., Ferrini, F., Caretto, A., Hassan, A., di Vito, R., Beltrando, G., Marnetto, D., Usiello, A., Cunto, F. D., Boido, M., et al. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08520-8 · Cited by 3

Neurodevelopmental Consequences Induced by Early‐Life Lead Exposure Through Disruption of Neurotransmitter Pathways and Molecular Mechanisms: A Systematic Review

Harshitha, P., Parithathvi, A., Mumbrekar, K. D., & Dsouza, H. S. (2026) · Developmental Neurobiology · doi:10.1002/dneu.70043 · Cited by 3

The function of chloride channels in digestive system disease (Review)

Hu, Y., & Tuo, B. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5540 · Cited by 3

Identification of the Shared Gene Signatures Between Alzheimer’s Disease and Diabetes-Associated Cognitive Dysfunction by Bioinformatics Analysis Combined with Biological Experiment

Chen, Y., Ji, X., & Bao, Z. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240353 · Cited by 3

Suppressing DUSP16 overexpression induced by ELK1 promotes neural progenitor cell differentiation in mouse models of Alzheimer's disease

Zhao, H., Mu, Y., Liang, A., Wei, J., Lai, S., Li, X., Chen, P., Li, H., He, H., Liu, X., et al. (2024) · Aging Cell · doi:10.1111/acel.14372 · Cited by 3

GABRB2 in Neuropsychiatric Disorders: Genetic Associations and Functional Evidences

Tsang, S. Y., Ullah, A., & Xue, H. (2019) · Current Psychopharmacologye · doi:10.2174/2211556008666190926115813 · Cited by 3

Subject-specific features of excitation/inhibition profiles in neurodegenerative diseasesPreprint

Monteverdi, A., Palesi, F., Costa, A. C., Vitali, P., Pichiecchio, A., Ramusino, M. C., Bernini, S., Jirsa, V., Wheeler‐Kingshott, C. A. M. G., & D'Angelo, E. U. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.23.473997 · Cited by 3

Regulation of Hippocamposeptal Synaptic Transmission by GABABRs Is Altered in 5XFAD Mice in a Sex- and Age-Dependent Manner

Damborsky, J. C., & Yakel, J. L. (2024) · Journal of Molecular Neuroscience · doi:10.1007/s12031-024-02260-0 · Cited by 2

Gut microbiome and cognitive function in the Hispanic Community Health Study/Study of Latinos

Palacios, N., Gordon, S., Wang, T., Burk, R. D., Qi, Q., Huttenhower, C., González, H. M., Knight, R. D., DeCarli, C. S., Daviglus, M., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251376911 · Cited by 2

GABAergic activity and gamma oscillations in Alzheimer’s disease and mild cognitive impairment: Neuropathology and therapeutic neuromodulatory insights from animal and human studies

Salehinejad, M. A., & Jouzdani, A. F. (2026) · Brain Network Disorders · doi:10.1016/j.bnd.2026.01.002 · Cited by 2

In silico design and development of benzyl piperazine conjugates for targeting choline esterase pathway in Alzheimer's disease

Sivaperuman, A., Dhanabalan, K., Natarajan, R., Nagarajan, N. C., Moorthy, N. D., & Solomon, V. R. (2026) · In Silico Research in Biomedicine · doi:10.1016/j.insi.2026.100315 · Cited by 2

Comparative proteomic analysis of cerebral cortex revealed neuroprotective mechanism of esculentoside A on Alzheimer's disease

He, Z., Zhang, H., Li, X., Shen, L., Li, N., Cheng, S., & Liu, Q. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.176226 · Cited by 2

Associations of Plasma Glutamatergic Metabolites with Alpha Desynchronization during Cognitive Interference and Working Memory Tasks in Asymptomatic Alzheimer’s Disease

Leong, V., Yu, J., Castor, K., Al‐Ezzi, A. A. A., Arakaki, X., & Fonteh, A. N. (2024) · Cells · doi:10.3390/cells13110970 · Cited by 2

Unscrambling the cellular and molecular threads of Neuroplasticity: Insights into Alzheimer’s disease pathogenesis

Kalra, P., Grewal, A. K., Khan, H., & Singh, T. G. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.02.037 · Cited by 2

Physiology, Ligand Gated Chloride Channel

Clar, D. T., & Maani, C. V. (2019) · StatPearls · Cited by 2

The Interplay of Nicotine and Social Stress Mediate Dopaminergic Neuron Firing in the Ventral Tegmental Area - Nucleus Accumbens Pathway, Contributing to Stress andDepressive Mood Disorder

Adams, D., Kaliss, N., Missner, A. A., & Valentine, M. M. (2021) · Georgetown Scientific Research Journal · doi:10.48091/suvn5250 · Cited by 2

Pre-Dominance Herbs Medicine against Alzheimer’s Disease, In Vivo Studies: A Literature Review

Suswidiantoro, V., Ridlawati, F., Karim, D. D. A., Pratiwi, M., Dwiningrum, R., Safutri, W., Putri, D. K., Pisacha, I. M., & Rahayu, K. W. (2023) · Jurnal Aisyah Jurnal Ilmu Kesehatan · doi:10.30604/jika.v8is1.1728 · Cited by 2

NMDA Receptor Activation and Ca2+/PKC Signaling in Nicotine-Induced GABA Transport Shift in Embryonic Chick Retina

Souto, A. C., Tempone, M. H., Gonçalves, L. A. C., Borges-Martins, V. P. P., Peixoto-Rodrigues, M. C., Damascena, A. C. O., Ferraz, G., Manhães, A. C., Castro, N. G., Reis, R. A. D. M., et al. (2023) · Neurochemical Research · doi:10.1007/s11064-023-03870-7 · Cited by 1

Зв’язок між мікробіомом кишечника та розвитком нейродегенеративних захворювань (огляд)

Широбоков, В. П., & Димент, Г. С. (2024) · Visnik Nacional noi academii nauk Ukrai ni · doi:10.15407/visn2024.07.077 · Cited by 2

Unraveling the role of polyamine metabolism in postoperative delirium: insights into biochemical mechanisms and biomarker potential

Saiyed, N., Pandya, V. K., Pan, X., Čuperlović‐Culf, M., Ashrafi, N., Kant, S., Migaud, M. E., Dhuguru, J., Zetterberg, H., McGuinness, B., et al. (2026) · npj Aging · doi:10.1038/s41514-025-00324-y · Cited by 1

Shared metabolic pathways in epilepsy and plant immunity: From evolution to diet

Liu, H., Kachroo, H., & Kachroo, P. (2026) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2026.102656 · Cited by 1

Dietary and biomarker‐guided strategies as supportive measures in the fragile X syndrome

Elhalawani, J. E., & AlOlaby, R. R. (2026) · Food biomacromolecules. · doi:10.1002/fob2.70049 · Cited by 1

From comorbidity to continuum: Alzheimer’s disease and epilepsy are connected-now what?

Alves, S. S., Manzine, P. R., dos Santos, F. M., Migliaccio, M. M., Alves, L. D. C., da Silva-Júnior, R. M. P., Becerra-Hernández, L. V., González-Acosta, C. A., Buriticá, E., Cominetti, M. R., et al. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106682 · Cited by 1

Acupuncture for Alzheimer’s disease: A systematic review and meta-analysis integrating traditional insights and scientific evidence

Huang, W., Wang, L.-L., Shi, J.-R., & Liu, Q. (2026) · Journal of Chinese Integrative Medicine · doi:10.1016/j.joim.2026.08.002 · Cited by 1

G protein-coupled receptors in neurodegenerative diseases

Guimarães, T. R., & Thathiah, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816228-6.00017-9 · Cited by 1

Cinco siglos circunnavegando el planeta

González, F. J. G. (2012) · Boletín de la Institución Libre de Enseñanza · Cited by 1

A promising therapeutic potential of Origanum vulgare extract in mitigating ethanol-induced working memory impairments and hippocampal oxidative stress in rats

Aliabadi, M., Valizadegan, F., Seyedalipour, B., Yaqubi, S., & Nazifi, E. (2024) · International Journal of Environmental Health Research · doi:10.1080/09603123.2024.2440898 · Cited by 1

Neurophysiological correlates of modifiable dementia risk factors in cognitively unimpaired older adults

Levenstein, J. M., Treacy, C., & Andrews, S. C. (2025) · Cerebral Cortex · doi:10.1093/cercor/bhaf179 · Cited by 1

Neurotransmitter Imaging of the Human Brain : Detecting γ-Aminobutyric Acid (GABA) Using Magnetic Resonance Spectroscopy

Tapper, S. (2019) · Linköping University medical dissertations · doi:10.3384/diss.diva-154904 · Cited by 1

Mitochondrial Antioxidant SkQ1 Affects the GABAergic but Not the Glutamatergic System in the Hippocampus of Wistar and Senescence Accelerated OXYS Rats

Telegina, D. V., & Kolosova, N. G. (2023) · Advances in Gerontology · doi:10.1134/s2079057024600058 · Cited by 1

The diazepam binding inhibitor’s modulation of the GABA-A receptor is subunit-dependentPreprint

Borchardt, J. S., Blecker, L. M., Tung, A. J., Satyshur, K. A., & Czajkowski, C. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.13.456294 · Cited by 1

The GABAergic System

Merino, P. (2019) · doi:10.1002/9783527813421.ch6 · Cited by 1

Gut Microbiome Multi-Omics and Cognitive Function in the Hispanic Community Health Study/Study of Latinos- Investigation of Neurocognitive AgingPreprint

Palacios, N., Gordon, S., Wang, T., Burk, R. D., Qi, Q., Huttenhower, C., González, H. M., Knight, R. D., DeCarli, C. S., Daviglus, M., et al. (2024) · medRxiv · doi:10.1101/2024.05.17.24307533 · Cited by 1

Triptolide Reduced Alzheimer's Disease-Like Presentation in MicePreprint

Mao, R., Xu, S., Sun, G., Yu, Y., Zuo, Z., Wang, Y., Yang, K. Y., Zhang, Z., & Yang, W. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3981437

Treatment Potential of Angiotensin Converting Enzyme Inhibitors in Alzheimer's Disease: Pros and Con: Traditional Review

BAŞOL, C., Kerry, Z., & Yetik-Anacak, G. (2022) · Journal of Literature Pharmacy Sciences · doi:10.5336/pharmsci.2021-87228

Neuropharmacology in Alzheimer and Huntington Disease

Gupta, B., & Rohatgi, K. (2022) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815040913122010015

Las orexinas como biomarcadores para demencia tipo Alzheimer y relación con síntomas neuropsiquiátricos

Lozano-Tovar, S., Monroy‐Jaramillo, N., & Rodríguez‐Agudelo, Y. (2022) · Revista chilena de neuro-psiquiatría · doi:10.4067/s0717-92272022000300313 · Cited by 1

Roles of Nutraceuticals in Regulating Neurotransmitters in Dementia

Othman, N. F. F., Singh, G. K. S., & Hazalin, N. A. M. N. (2023) · Advances in Pharmacology and Pharmacy · doi:10.13189/app.2023.110201

Deciphering New Drug Targets in Alzheimer’s Disease

Verma, N., Thapa, K., Kanojia, N., Kaur, G., Sood, P., & Dua, K. (2023) · Springer eBooks · doi:10.1007/978-981-99-2657-2_1

Análise do transcriptoma da região do subiculum de modelo animal de epilepsia do lobo temporal mesial (ELTM) induzido por estimulação elétrica da via perfurante

Aoyama, B. B. (2020) · doi:10.47749/t/unicamp.2020.1161312

Effects of Medicinal Plants and Phytochemicals on Schizophrenia

Mükemre, M., & Dalar, A. (2024) · doi:10.69860/nobel.9786053359241.6

Deciphering the molecular and neuropathological dimensions of dementia

Dutta, S., Bhattacharjee, P., Noori, S., Adhikari, N., Dule, S., Soyel, M. I., Besra, M., Borah, S., & Gupta, P. (2025) · NPG. Neurologie, psychiatrie, gériatrie/NPG · doi:10.1016/j.npg.2025.05.002

Lifestyle, Diet, and the Gut–Brain Axis in Neuroprotection

Sharma, P., Verma, N., Verma, A., Wal, A., Kumar, S., & Upadhyay, P. (2025) · Springer eBooks · doi:10.1007/978-981-95-3945-1_16

Neurological aging and neurodegenerative disease in humans and great apes

Edler, M. K., Hearn, C. J., Guevara, E. E., Mhatre‐Winters, I., Varghese, M., Freire‐Cobo, C., Sherwood, C. C., Richardson, J. R., Raghanti, M. A., & Hof, P. R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-27380-3.00074-9

Additional file 1 of Associations between gut microbiota and Alzheimer’s disease, major depressive disorder, and schizophrenia

Zhuang, Z., Yang, R., Wang, W., Qi, L., & Huang, T. (2020) · Figshare · doi:10.6084/m9.figshare.13047173

Additional file 1 of Parvalbumin neuroplasticity compensates for somatostatin impairment, maintaining cognitive function in Alzheimer’s disease

Morrone, C. D., Lai, A. Y., Bishay, J., Hill, M. E., & McLaurin, J. (2022) · Figshare · doi:10.6084/m9.figshare.19695705

Novel drug candidate binds to delta subunit containing GABAA receptors and improves spatial memory

Huzián, O., Nagy, L. I., Hackler, L., Knapp, L., Kocsis, Á. K., Szöts, I., Tamás, G., Puskás, L. G., & Molnár, G. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.118970

Longitudinal 7T MRS Study of Glutamate and GABA Dynamics in Alzheimer’s Disease Progression: From hyper- to hypoexcitationPreprint

Göschel, L., Dell’Orco, A., Aydın, S., Teunissen, C. E., Hoede, P. L., Melin, J., Pendrill, L., Roemer, S. N., Franzmeier, N., Flöel, A., et al. (2026) · medRxiv · doi:10.64898/2026.02.04.26345353

The β-amyloid-induced increased tonic conductance, impaired long-term potentiation and cognitive deficits characteristic of Alzheimer's disease are reversed by an α5 inverse agonist of the GABA type A receptor

O'connell, A., Guzmán, B. C., Zhai, Y., Keighron, C. N., Boix, J., Peppercorn, K., Tate, W. P., Waldvogel, H. J., Faull, R. L. M., Montgomery, J. M., et al. (2026) · Neuropharmacology · doi:10.1016/j.neuropharm.2026.110892 · Cited by 1

The GABAergic system as a therapeutic target for Alzheimer's disease

Guzmán, B. C., Vinnakota, C., Govindpani, K., Waldvogel, H. J., Faull, R. L. M., & Kwakowsky, A. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14345 · Cited by 172

Recent progress on the role of GABAergic neurotransmission in the pathogenesis of Alzheimer’s disease

Abbas, G., Mahmood, W., & Kabir, N. (2016) · Reviews in the Neurosciences · doi:10.1515/revneuro-2015-0062 · Cited by 18

IMPORTANT ROLE PLAYS OF GABA AND ITS TYPES IN ALZHEIMER'S DISEASE: A REVIEW

SUSMITA MANDAL, A. V. (2025) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.15771291

Implications of GABAergic Neurotransmission in Alzheimer’s Disease

Li, Y., Sun, H., Chen, Z., Xu, H., Bu, G., & Zheng, H. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00031 · Cited by 282

GABAergic neurotransmission and new strategies of neuromodulation to compensate synaptic dysfunction in early stages of Alzheimer’s disease

Nava-Mesa, M. O., Jiménez‐Díaz, L., Yajeya, J., & Navarro‐López, J. D. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00167 · Cited by 106